SAN RAMON, Calif.--(BUSINESS WIRE)--rfXcel Corp., the leader in serialization, traceability, and DSCSA and global compliance in the private cloud for the life sciences industry, is continuing to deliver real-world solutions to help life sciences customers meet their needs. rfXcel announced today many pharmaceutical manufacturers are now fully compliant with the US Drug Supply Chain Security Act (DSCSA) via the rfXcel Traceability System™ (rTS). Customers are now able to provide DSCSA Transaction Information (TI), Transaction History (TH), and Transaction Statement (TS) reports on all products shipped to many trading partners on the rfXchange™ trading network, including the “Big Three” pharmaceutical distributors - McKesson, Cardinal Health, and Amerisource Bergen. In addition, rfXcel has set up a host of wholesalers and distributors to receive DSCSA reports from, and produce compliant reports for, their trading partners. Most importantly, every customer that is now “live” has gone through a rigorous data validation process to ensure ongoing success.
Help employers find you! Check out all the jobs and post your resume.
